The IRCM Salutes a Major Honour Bestowed Upon Dr. Javier Di Noia
The Montreal Clinical Research Institute (IRCM) is pleased to highlight the distinction received by Dr. Javier Di Noia, recipient of the Investigator award by the Canadian Society for Immunology (CSI) for its 2026 annual edition. This recognition, which will be presented at the CSI's annual scientific meeting, recognizes the excellence and impact of Dr. Di Noia's contributions to the advancement of Canadian immunology.
An International Leader in B Cell Biology
Director of the B Cell Molecular Biology Research Unit at the IRCM, a Professor in the Department of Medicine at the Université de Montréal, and an Associate Professor at McGill University, Dr. Di Noia is recognized worldwide for his discoveries on antibody diversification, a fundamental process for the immune response.
His work has profoundly renewed our understanding of the role of the activation-induced deaminase (AID) enzyme, which is responsible for the programmed mutations that allow antibodies to increase their affinity and change isotype. More specifically, Dr. Di Noia has contributed to elucidating:
- the molecular mechanisms controlling targeted mutagenesis of antibody genes
- the processes that allow B lymphocytes to survive in the demanding microenvironment of the germinal centre
- the delicate balance between beneficial diversification and oncogenic risk associated with AID activity.
His publications in leading journals, including Nature Communications and the Journal of Experimental Medicine, are helping to shape the field of modern molecular immunology.
A Well-Deserved Recognition
This award from the Canadian Society for Immunology recognizes Dr. Di Noia's remarkable career and major scientific influence. His research contributes directly to our understanding of human immunodeficiencies, the biology of lymphomas, and the essential role of antibodies in human health.
The IRCM warmly congratulates Dr. Javier Di Noia on this prestigious distinction and salutes his entire team, whose scientific excellence continues to illuminate the landscape of biomedical research in Canada.
